All In Biotech

Drug Trial Radar · NCT01427296

Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

A Phase 4, Randomized, Active Comparator, Open-Label, Multicenter Study to Assess the Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

Last checked: Nov 20, 2026Latest source record: Jan 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 2,154 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,154

Actual

Start

Sep 16, 2011

Primary completion

Mar 11, 2014

Study completion Dec 9, 2014

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
First posted
Sep 1, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.

Conditions

  • Colon Cleansing

Interventions

  • Polyethylene glycolDrug

    HalfLytely and Bisacodyl Tablet Bowel Prep Kit, administered as 1 bisacodyl tablet followed by HalfLytely oral solution in a total liquid volume of approximately 2 L

  • Oral sodium phosphate solutionDrug

    OsmoPrep tablets (48 g), administered as 32 total tablets in a total liquid volume of approximately 2 L

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Distribution of the Overall Colon-cleansing Scale in Each Treatment Group.Time frame: 6 months

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    San Carlos, California

  • Site not named

    Bristol, Connecticut

  • Site not named

    Macon, Georgia

  • Site not named

    Suwanee, Georgia

  • Site not named

    Hagerstown, Maryland

  • Site not named

    Wyoming, Michigan

  • Site not named

    Mexico, Missouri

  • Site not named

    Vineland, New Jersey

  • Site not named

    Great Neck, New York

  • Site not named

    New York, New York

  • Site not named

    Fayetteville, North Carolina

  • Site not named

    High Point, North Carolina

  • Site not named

    Raleigh, North Carolina

  • Site not named

    Cincinnati, Ohio

  • Site not named

    Mentor, Ohio

  • Site not named

    Plano, Texas

  • Site not named

    Chesapeake, Virginia

  • Site not named

    Bellevue, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.